cefazolin

Generic: cefazolin sodium

Labeler: Sagent Pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive

Drug Facts

Product Profile

Brand Name cefazolin
Generic Name cefazolin sodium
Labeler Sagent Pharmaceuticals
Dosage Form INJECTION, POWDER, FOR SOLUTION
Routes
INTRAMUSCULAR INTRAVENOUS
Active Ingredients

CEFAZOLIN SODIUM 500 mg/2.2mL

Identifiers & Regulatory

Product NDC 25021-100
Product ID 25021-100_158968cf-18f0-4590-b2ac-2e654802686c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA065303
Marketing Start 2009-02-01
Marketing End 2026-02-28

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 25021100
Hyphenated Format 25021-100

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cefazolin (source: ndc)
Generic Name cefazolin sodium (source: ndc)
Application Number ANDA065303 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 500 mg/2.2mL
source: ndc
Packaging
  • 25 VIAL in 1 CARTON (25021-100-10) / 2.2 mL in 1 VIAL
source: ndc

Packages (1)

Ingredients (1)

CEFAZOLIN SODIUM (500 mg/2.2mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "158968cf-18f0-4590-b2ac-2e654802686c", "openfda": {"unii": ["P380M0454Z"], "rxcui": ["1665050", "1665052"], "spl_set_id": ["e8f40f72-3cf0-43dc-a797-fb98dd8af228"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (25021-100-10)  / 2.2 mL in 1 VIAL", "package_ndc": "25021-100-10", "marketing_end_date": "20260228", "marketing_start_date": "20090201"}], "brand_name": "cefazolin", "product_id": "25021-100_158968cf-18f0-4590-b2ac-2e654802686c", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Cephalosporin Antibacterial [EPC]", "Cephalosporins [CS]"], "product_ndc": "25021-100", "generic_name": "cefazolin sodium", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "cefazolin", "active_ingredients": [{"name": "CEFAZOLIN SODIUM", "strength": "500 mg/2.2mL"}], "application_number": "ANDA065303", "marketing_category": "ANDA", "marketing_end_date": "20260228", "marketing_start_date": "20090201"}